PT Charlie Hospital Semarang Tbk (IDX:RSCH)
478.00
-6.00 (-1.24%)
At close: May 2, 2025, 3:30 PM WIB
IDX:RSCH Revenue
PT Charlie Hospital Semarang Tbk had revenue of 11.93B IDR in the quarter ending March 31, 2025, a decrease of -4.79%. This brings the company's revenue in the last twelve months to 47.90B, up 6.20% year-over-year. In the year 2024, PT Charlie Hospital Semarang Tbk had annual revenue of 48.50B with 15.04% growth.
Revenue (ttm)
47.90B
Revenue Growth
+6.20%
P/S Ratio
26.22
Revenue / Employee
223.84M
Employees
214
Market Cap
1,256.10B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 48.50B | 6.34B | 15.04% |
Dec 31, 2023 | 42.16B | 9.13B | 27.63% |
Dec 31, 2022 | 33.03B | -2.52B | -7.10% |
Dec 31, 2021 | 35.56B | 22.29B | 168.08% |
Dec 31, 2020 | 13.26B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
PT Kalbe Farma Tbk. | 33.11T |
PT Mitra Keluarga Karyasehat Tbk | 4,726.29B |
PT Sejahteraraya Anugrahjaya Tbk | 3,202.64B |
PT Siloam International Hospitals Tbk | 12.21T |
PT Medikaloka Hermina Tbk | 6,703.24B |
PT Industri Jamu dan Farmasi Sido Muncul Tbk | 3,654.77B |
PT Tempo Scan Pacific Tbk | 13.49T |
PT Famon Awal Bros Sedaya Tbk | 2,103.06B |